| Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease N Mattsson-Carlgren, S Janelidze, S Palmqvist, N Cullen, ... Brain 143 (11), 3234-3241, 2020 | 231 | 2020 |
| Detection of aggregation-competent tau in neuron-derived extracellular vesicles FX Guix, GT Corbett, DJ Cha, M Mustapic, W Liu, D Mengel, Z Chen, ... International journal of molecular sciences 19 (3), 663, 2018 | 197 | 2018 |
| Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone SA Purro, MA Farrow, J Linehan, T Nazari, DX Thomas, Z Chen, ... Nature 564 (7736), 415-419, 2018 | 182 | 2018 |
| miR-212 and miR-132 are downregulated in neurally derived plasma exosomes of Alzheimer’s patients DJ Cha, D Mengel, M Mustapic, W Liu, DJ Selkoe, D Kapogiannis, ... Frontiers in neuroscience 13, 1208, 2019 | 171 | 2019 |
| Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease Z Chen, D Mengel, A Keshavan, RA Rissman, A Billinton, M Perkinton, ... Alzheimer's & Dementia 15 (3), 487-496, 2019 | 119 | 2019 |
| Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid T Yang, Y Dang, B Ostaszewski, D Mengel, V Steffen, C Rabe, T Bittner, ... Annals of neurology 86 (2), 215-224, 2019 | 92 | 2019 |
| Measuring compounds in exhaled air to detect Alzheimer's disease and Parkinson’s disease JP Bach, M Gold, D Mengel, A Hattesohl, D Lubbe, S Schmid, ... PloS one 10 (7), e0132227, 2015 | 72 | 2015 |
| GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response C Wilke, D Pellerin, D Mengel, A Traschütz, MC Danzi, MJ Dicaire, ... Brain 146 (10), 4144-4157, 2023 | 64 | 2023 |
| Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer’s disease F Brosseron, A Maass, L Kleineidam, KA Ravichandran, PG González, ... Neuron 110 (6), 1009-1022. e4, 2022 | 47 | 2022 |
| α 1-antitrypsin modulates microglial-mediated neuroinflammation and protects microglial cells from amyloid-β-induced toxicity M Gold, AM Dolga, J Koepke, D Mengel, C Culmsee, R Dodel, ... Journal of neuroinflammation 11, 1-11, 2014 | 47 | 2014 |
| Naturally occurring autoantibodies interfere with β-amyloid metabolism and improve cognition in a transgenic mouse model of Alzheimer’s disease 24 h after single treatment D Mengel, S Röskam, F Neff, K Balakrishnan, O Deuster, M Gold, ... Translational psychiatry 3 (3), e236-e236, 2013 | 39 | 2013 |
| Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia M Gold, D Mengel, S Röskam, R Dodel, JP Bach Journal of neuroinflammation 10, 1-9, 2013 | 36 | 2013 |
| Plasma NT1 tau is a specific and early marker of Alzheimer's disease D Mengel, S Janelidze, RJ Glynn, W Liu, O Hansson, DM Walsh Annals of Neurology 88 (5), 878-892, 2020 | 34 | 2020 |
| Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS M Chatterjee, S Özdemir, C Fritz, W Möbius, L Kleineidam, E Mandelkow, ... Nature Medicine, 1-13, 2024 | 33 | 2024 |
| Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase D Mengel, W Liu, RJ Glynn, DJ Selkoe, A Strydom, F Lai, HD Rosas, ... Alzheimer's Research & Therapy 12, 1-11, 2020 | 31 | 2020 |
| Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease D Mengel, J Dams, J Ziemek, J Becker, M Balzer-Geldsetzer, R Hilker, ... Parkinsonism & related disorders 29, 112-116, 2016 | 31 | 2016 |
| Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study F Brosseron, A Maass, L Kleineidam, KA Ravichandran, CC Kolbe, ... Alzheimer's research & therapy 15 (1), 13, 2023 | 29 | 2023 |
| Costs of illness in chronic inflammatory demyelinating polyneuropathy in Germany D Mengel, L Fraune, N Sommer, M Stettner, JP Reese, J Dams, RJ Glynn, ... Muscle & nerve 58 (5), 681-687, 2018 | 29 | 2018 |
| The endogenous α7 nicotinic acetylcholine receptor antagonist kynurenic acid modulates amyloid-β-induced inflammation in BV-2 microglial cells L Steiner, M Gold, D Mengel, R Dodel, JP Bach Journal of the Neurological Sciences 344 (1-2), 94-99, 2014 | 29 | 2014 |
| The role of CNI-1493 in the function of primary microglia with respect to amyloid-β JP Bach, D Mengel, T Wahle, A Kautz, M Balzer-Geldsetzer, Y Al-Abed, ... Journal of Alzheimer's Disease 26 (1), 69-80, 2011 | 28 | 2011 |